Correlation
The correlation between CORT and AVAV is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
CORT vs. AVAV
Compare and contrast key facts about Corcept Therapeutics Incorporated (CORT) and AeroVironment, Inc. (AVAV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CORT or AVAV.
Performance
CORT vs. AVAV - Performance Comparison
Loading data...
Key characteristics
CORT:
1.24
AVAV:
-0.22
CORT:
3.64
AVAV:
0.05
CORT:
1.50
AVAV:
1.01
CORT:
3.19
AVAV:
-0.20
CORT:
8.12
AVAV:
-0.39
CORT:
17.89%
AVAV:
26.55%
CORT:
121.27%
AVAV:
50.86%
CORT:
-94.28%
AVAV:
-61.02%
CORT:
-32.10%
AVAV:
-24.30%
Fundamentals
CORT:
$8.23B
AVAV:
$8.05B
CORT:
$1.15
AVAV:
$1.14
CORT:
67.51
AVAV:
151.31
CORT:
0.61
AVAV:
1.72
CORT:
12.01
AVAV:
10.84
CORT:
12.05
AVAV:
9.35
CORT:
$685.45M
AVAV:
$545.58M
CORT:
$674.70M
AVAV:
$216.60M
CORT:
$111.33M
AVAV:
$45.86M
Returns By Period
In the year-to-date period, CORT achieves a 53.92% return, which is significantly higher than AVAV's 15.69% return. Over the past 10 years, CORT has outperformed AVAV with an annualized return of 28.58%, while AVAV has yielded a comparatively lower 21.13% annualized return.
CORT
53.92%
7.90%
34.47%
148.51%
54.97%
38.64%
28.58%
AVAV
15.69%
17.50%
-8.47%
-11.18%
24.63%
20.24%
21.13%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CORT vs. AVAV — Risk-Adjusted Performance Rank
CORT
AVAV
CORT vs. AVAV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and AeroVironment, Inc. (AVAV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
CORT vs. AVAV - Dividend Comparison
Neither CORT nor AVAV has paid dividends to shareholders.
Drawdowns
CORT vs. AVAV - Drawdown Comparison
The maximum CORT drawdown since its inception was -94.28%, which is greater than AVAV's maximum drawdown of -61.02%. Use the drawdown chart below to compare losses from any high point for CORT and AVAV.
Loading data...
Volatility
CORT vs. AVAV - Volatility Comparison
The current volatility for Corcept Therapeutics Incorporated (CORT) is 9.13%, while AeroVironment, Inc. (AVAV) has a volatility of 11.09%. This indicates that CORT experiences smaller price fluctuations and is considered to be less risky than AVAV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
CORT vs. AVAV - Financials Comparison
This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and AeroVironment, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CORT vs. AVAV - Profitability Comparison
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a gross profit of 154.81M and revenue of 157.21M. Therefore, the gross margin over that period was 98.5%.
AVAV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AeroVironment, Inc. reported a gross profit of 63.20M and revenue of 167.64M. Therefore, the gross margin over that period was 37.7%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported an operating income of 3.42M and revenue of 157.21M, resulting in an operating margin of 2.2%.
AVAV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AeroVironment, Inc. reported an operating income of -3.09M and revenue of 167.64M, resulting in an operating margin of -1.8%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a net income of 20.29M and revenue of 157.21M, resulting in a net margin of 12.9%.
AVAV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AeroVironment, Inc. reported a net income of -1.75M and revenue of 167.64M, resulting in a net margin of -1.1%.